GlassScriptPhysician profile
Rebecca L Russo
NPI 1093119216
$1,133.75
in general payments reported to CMS, 2019-2025
16 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $118 · 2022: $264 · 2023: $206 · 2024: $160 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $233.11 | 2023-2025 | Orgovyx, Gemtesa |
| Abbott Laboratories | $165.48 | 2025 | Proclaim |
| Pfizer INC. | $112.53 | 2021-2023 | |
| Janssen Biotech, INC. | $109.16 | 2021-2023 | Erleada |
| Myovant Sciences INC. | $106.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.31 | 2024-2025 | |
| Teleflex LLC | $64.74 | 2023-2024 | Urolift |
| Coloplast Corp | $51.08 | 2023-2024 | Speedicath |
| Rochester Medical Corporation | $50.74 | 2022 | |
| Progenics Pharmaceuticals, INC. | $37.89 | 2023-2024 | Pylarify |
| Immunitybio, INC. | $27.44 | 2025 | |
| Urovant Sciences INC | $22.15 | 2022 | |
| Urogen Pharma, INC. | $21.82 | 2025 | |
| Endo Pharmaceuticals INC. | $21.10 | 2021 | |
| Antares Pharma, INC. | $20.55 | 2024 | Xyosted |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $15.65 | 2025 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.